A NOVEL NON-H-1, NON-H-2 HISTAMINE ANTAGONIST PROTECTS AGAINST CYSTEAMINE-INDUCED DUODENAL-ULCERS IN RATS

被引:2
作者
GLAVIN, GB
BRANDES, LJ
机构
[1] UNIV MANITOBA,FAC MED,DEPT SURG,WINNIPEG R3E 0W3,MANITOBA,CANADA
[2] UNIV MANITOBA,MANITOBA INST CELL BIOL,DEPT MED,WINNIPEG R3E 0W3,MANITOBA,CANADA
关键词
D O I
10.1159/000138477
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:277 / 280
页数:4
相关论文
共 14 条
[1]   EFFECT OF VERAPAMIL ON GASTRIC-SECRETION IN MAN [J].
AADLAND, E ;
BERSTAD, A .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1983, 18 (07) :969-971
[2]  
BRANDES L, 1988, IN PRESS CANCER RES
[3]   A DIPHENYLMETHANE DERIVATIVE SELECTIVE FOR THE ANTI-ESTROGEN BINDING-SITE MAY HELP DEFINE ITS BIOLOGICAL ROLE [J].
BRANDES, LJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 124 (01) :244-249
[4]   A DIPHENYLMETHANE DERIVATIVE SPECIFIC FOR THE ANTIESTROGEN BINDING-SITE FOUND IN RAT-LIVER MICROSOMES [J].
BRANDES, LJ ;
HERMONAT, MW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 123 (02) :724-728
[5]   THE ANTIPROLIFERATIVE PROPERTIES OF TAMOXIFEN AND PHENOTHIAZINES MAY BE MEDIATED BY A UNIQUE HISTAMINE-RECEPTOR (QUESTIONABLE-H-3) DISTINCT FROM THE CALMODULIN-BINDING SITE [J].
BRANDES, LJ ;
BOGDANOVIC, RP ;
CAWKER, MD ;
BOSE, R .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1986, 18 (01) :21-23
[6]  
BRANDES LJ, 1987, CANCER RES, V47, P4025
[7]   NEW EVIDENCE THAT THE ANTIESTROGEN BINDING-SITE MAY BE A NOVEL GROWTH-PROMOTING HISTAMINE-RECEPTOR (QUESTIONABLE-H-3) WHICH MEDIATES THE ANTIESTROGENIC AND ANTIPROLIFERATIVE EFFECTS OF TAMOXIFEN [J].
BRANDES, LJ ;
BOGDANOVIC, RP .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 134 (02) :601-608
[8]   COMPARING BINDING OF HISTAMINE AND H2-ANTAGONIST WITH THEIR EFFECTS ON GASTRIC-ACID SECRETION [J].
EKBLAD, EBM ;
LICKO, V .
BIOCHIMICA ET BIOPHYSICA ACTA, 1987, 923 (02) :315-322
[9]  
GLAVIN G, 1988, IN PRESS CAN J PHYSL
[10]  
GLAVIN G, 1988, IN PRESS J PHARM PHA, V40